21 December 2021

Polpharma published the Corporate Social Responsibility Report for 2019-2020

The report presents the company's activity in the sustainable development area in the reported period and how it responds to the challenges of today's world: climate change, social and health-related issues.

As Poland’s largest manufacturer of medicines, including hospital drugs used in the treatment of covid complications, we are aware of the related responsibility. That is why, during the pandemic, we focused primarily on ensuring continuity of our production, tackling numerous challenges to make sure that the necessary medicines remain available to Polish patients. This approach is aligned with the objectives of our CSR strategy, which is based on the following pillars: serving the patients and the community, ethical conduct of business, innovation and advancing knowledge.

People are in the center of what we do. The report provides specific examples of:
– How we educate and what health prevention activities we carry out
– What ethical principles guide our day to day operations
– How we make life easier by using new technologies
– How we care for our employees
– Our actions for the climate and the environment

We would like to thank everyone who contributed to this report by participating in the survey of our social stakeholders. We do hope that the publication will meet your expectations.

The report is available here>>

The Corporate Social Responsibility Report of the Polpharma Group in Poland 2019-2020 has been prepared in accordance with standards for sustainability reporting The GRI Standards Core option and reviewed independently.

Polpharma on its websites and mobile applications (“Website”) uses cookies and other related technologies (“cookies”). Self-management of cookies is possible by changing the settings in your web browser. If you do not agree to the collection of personal data through cookies, you can change the settings in your web browser or leave the Website.

By using the Website without changing the settings in your web browser, you accept Polpharma’s use of cookies. By accepting the settings in your web browser, you agree to profiling based on the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect the lawfulness of the processing that was carried out on the basis of consent before its withdrawal.

More information can be found in the Cookies Policy.